[1]

赵辨.中国临床皮肤病学[M].南京: 江苏科学技术出版社, 2009: 1008.
[2] Capon F, Dallapiccola B, Novelli G. Advances in the search for psoriasis susceptibility genes[J]. Mol Genet Metab, 2000, 71(1/2):250-255.
[3] 杨雪琴.银屑病与心身医学[J].人民军医, 2004, 47(8):481-484.
[4]

张奇亮.敷贴治疗核医学[M].济南: 济南出版社, 2004: 53.
[5] 鲁智勇, 姚志荣, 戴红, 等.国产卡泊三醇软膏治疗寻常性银屑病多中心临床研究[J].中华皮肤科杂志, 2010, 43(9):645-646.
[6] 黄岚, 马莉, 黄琼, 等.钙泊三醇倍他米松软膏外用治疗寻常性银屑病的随机、双盲、对照研究[J].中华皮肤科杂志, 2009, 42(10):691-694.
[7] 罗绍淼, 范敏, 苏禧, 等. NB-UVB联合中药浴治疗寻常性银屑病的临床观察[J].中华皮肤科杂志, 2010, 43(4):284-285.
[8] Nast A, Kopp I, Augustin M, et al. German evidence-based guidelines for the treatment of Psoriasis vulgaris(short version)[J]. Arch Dermatol Res, 2007, 299(3):111-138.
[9] Katugampola RP, Hongbo Y, Finlay AY. Clinical management decisions are related to the impact of psoriasis on patient-rated quality of life[J]. Br J Dermatol, 2005, 152(6):1256-1262.
[10]

黄钢.核医学与分子影像临床操作规范[M]. 2版.北京: 人民卫生出版社, 2014: 316.
[11] 陈菊华, 黄春艳.复方氨肽素对进展期寻常型银屑病的疗效观察[J].现代医药卫生, 2006, 22(4):496-497.